The global Asthma Therapeutics Market is expanding as the burden of asthma continues to increase and healthcare systems place greater emphasis on early diagnosis, long-term disease management, and improved symptom control.

According to Fortune Business Insights, the global asthma therapeutics market was valued at USD 26.93 billion in 2025 and is projected to grow from USD 27.92 billion in 2026 to USD 35.27 billion by 2034, exhibiting a CAGR of 3.06% during the forecast period.

Why is the Asthma Therapeutics Market Growing?

The increasing prevalence of asthma and the growing number of patients requiring long-term disease management are major factors driving the market. Asthma treatment typically involves controlling airway inflammation, relieving symptoms, and preventing exacerbations, creating ongoing demand for maintenance and rescue therapies.

Asthma therapeutics are increasingly used for:

• Long-term asthma control
• Acute symptom relief
• Prevention of exacerbations
• Moderate-to-severe asthma
• Severe eosinophilic asthma
• Allergic asthma
• Pediatric asthma
• Adult asthma
• Maintenance therapy
• Personalized respiratory care

Increasing awareness of asthma, growing access to pulmonary specialists, and improvements in inhaler technologies are also supporting treatment uptake.

Key Market Trends Shaping Industry Growth

Increasing Prevalence of Asthma

The rising prevalence of asthma worldwide is increasing the number of patients requiring pharmacological treatment. Urbanization, air pollution, allergens, occupational exposures, and other environmental factors are contributing to the continuing disease burden.

Growing Adoption of Inhaled Therapies